Ritsuzo Kozuka

Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B

Yao‐Chun Hsu, Grace Lai–Hung Wong, Chien‐Hung Chen et al. · The American Journal of Gastroenterology · 2019 · 99 citations

Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy

Hwai‐I Yang, Ming‐Lun Yeh, Grace Lai–Hung Wong et al. · The Journal of Infectious Diseases · 2019 · 91 citations

Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase

Daniel Q. Huang, Andrew Tran, Ming‐Lun Yeh et al. · Hepatology · 2023 · 83 citations

Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B

Yao‐Chun Hsu, Ming‐Lun Yeh, Grace Lai–Hung Wong et al. · The Journal of Infectious Diseases · 2021 · 74 citations

Short‐term histological evaluations after achieving a sustained virologic response to direct‐acting antiviral treatment for chronic hepatitis C

Masaru Enomoto, Yoshihiro Ikura, Akihiro Tamori et al. · United European Gastroenterology Journal · 2018 · 40 citations · Full text